SAXINGER advised Medlog S.A. on the acquisition of a 50% stake with joint control in Yellow2Rail GmbH

SAXINGER was engaged by Medlog S.A., Switzerland, an indirectly wholly owned subsidiary of MSC Mediterranean Shipping Company Holding S.A., to advise on a joint venture related to the production and financing of market-leading rolling stock.

The team, consisting of partners Dr. Lukas Leitner, Dr. Christina Hummer, and Dr. Hanno Liebmann, advised Medlog S.A. on the acquisition of a 50% stake with joint control in Yellow2Rail GmbH, Austria, a member of the InnoFreight Group, as well as on a sale and lease back transaction by the joint venture company for rolling stock from the InnoFreight Group.

SAXINGER was responsible for drafting all transaction documents (including the share purchase agreements, shareholders’ agreements, all corporate governance-related documents, and matters related to railway law), as well as for obtaining merger control clearances in Austria, Germany, and Poland. SAXINGER worked closely together with the partner law firms of Saxinger Schindhelm Services SE (Schindhelm Germany and SDZLEGAL Schindhelm Poland).